Steroid-Induced Ocular Hypertension in Mice Is Differentially Reduced by Selective EP2, EP3, EP4, and IP Prostanoid Receptor Agonists

Sharif N.A.; Millar J.C.; Zode G.; Ota T.

2024
International Journal of Molecular Sciences

Therapeutic Area

Glaucoma
Categories

Preclinical development

Affiliations

Ophthalmology Innovation Center, Santen Inc., Emeryville, 94608, CA, United States; Institute of Ophthalmology, University College London (UCL), London, EC1V 9EL, United Kingdom; Department of Ophthalmology, Imperial College of Science and Technology, St. Mary’s Campus, London, W2 1PG, United Kingdom; Department of Ophthalmology, Eye-ACP Duke-National University of Singapore Medical School, Singapore, 119228, Singapore; Singapore Eye Research Institute (SERI), Singapore, 168751, Singapore; Department of Pharmacy Sciences, Creighton University, Omaha, 68178, NE, United States; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Texas Southern University, Houston, 77004, TX, United States; Department of Pharmacology & Neuroscience, North Texas Eye Research Institute (NTERI), University of North Texas Health Science Center, Fort Worth, 76107, TX, United States; Department of Ophthalmology and Center for Translational Vision Research, University of California, Irvine, 92617, CA, United States; Ophthalmology Innovation Center, Santen Pharmaceutical Co., Ltd., Nara, 630-0101, Japan

Related Publications

Associations between Clustered Visual Field Progression and Locations of Disc Hemorrhages in Glaucoma: A Three-year Prospective Study

Akagi T.; Fukuchi T.; Higashide T.; Udagawa S.; Ohkubo S.; Sugiyama K.; Tanihara H.; Araie M.; Tomita G.; Matsumoto C.; Tomidokoro A.; Hangai M.; Kawata H.; Inai M.; Tanaka Y.; SVF Prospector Study Group

Proteome-Wide Analysis of Autoantibodies in Open-Angle Glaucoma in Japanese Population: A Pilot Study

Takada N.; Ishikawa M.; Sato K.; Kunikata H.; Ninomiya T.; Hanyuda A.; Fukuda E.; Yamaguchi K.; Ono C.; Kirihara T.; Shintani C.; Tsusu C.; Osanai A.; Goshima N.; Izumi Y.; Zorumski C.F.; Nakazawa T.

Bioequivalence of Preservative-free and Preserved Omidenepag Isopropyl (OMDI) 0.002% Ophthalmic Solutions in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: Results from the Phase 3 DAISY Study

Aihara M.; Lu F.; Ikeda T.; Odani-Kawabata N.